NEW YORK, Jan. 28, 2025 /PRNewswire/ — Report with market evolution powered by AI – The global beta lactam and beta lactamase inhibitors market size is estimated to grow by USD 8.4 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 4.7% during…
Month: January 2025
NEW YORK, Jan. 28, 2025 /PRNewswire/ — Report with market evolution powered by AI – The global ticket market size is estimated to grow by USD 554.2 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 29.7% during the forecast period. Success of…
BEIJING, Jan. 28, 2025 /PRNewswire/ — This year’s Spring Festival Gala, an annual celebration produced and broadcast by China Media Group, commenced on Tuesday, the eve of the Chinese New Year, as Chinese people worldwide celebrated the Spring Festival, the most important Chinese…
LOS ANGELES, Jan. 28, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Symbotic Inc. (“Symbotic” or “the Company”) (NASDAQ: SYM) for violations of ยงยง10(b) and 20(a) of the Securities Exchange Act…
NEW YORK, Jan. 28, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of TELUS International (Cda) Inc. (“Telus” or the “Company”) (NASDAQ: TIXT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Jan. 28, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQ: FTAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…
NEW YORK, Jan. 28, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Transocean Ltd. (“Transocean” or the “Company”) (NYSE: RIG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Jan. 28, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Jan. 28, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQ: NXT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Jan. 28, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…